Sign inJoin waitlistJoin the waitlist

CP

Carol Portlock

Medical Oncology

Credentials: ·

History

Medical Oncology
Internal Medicine

Research

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma
Journal of Clinical Oncology · 2005 · 468 citations
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic…
Journal of Clinical Oncology · 2006 · 346 citations
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic…
Blood · 2001 · 332 citations

AZ
Andrew Zelenetz
47 papers
Craig Moskowitz
44 papers
DS
David Straus
43 papers
AN
Ariela Noy
37 papers
PH
Paul Hamlin
30 papers · 1 as a fellow
Joachim Yahalom
27 papers
SH
Steven Horwitz
19 papers
Lia Palomba
16 papers
OO
Owen O’Connor
16 papers
JG
John Gerecitano
15 papers
DF
Daniel Filippa
14 papers
Matthew Matasar
14 papers